The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 80 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| ALLERGAN PLC | SHS | G0177J108 | 127,083 | 868,000 | SH | SOLE | 868,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 124,018 | 524,658 | SH | SOLE | 524,658 | 0 | 0 | ||
| INNOVIVA INC | COM | 45781M101 | 84,546 | 6,026,100 | SH | SOLE | 6,026,100 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS INC | COM | 45845P108 | 35,795 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
| IRONWOOD PHARMACEUTICALS INC. | COM CLA | 46333X108 | 102,045 | 7,542,200 | SH | SOLE | 7,542,200 | 0 | 0 | ||
| JAZZ PHARMACEUTICALS INC | COM | G50871105 | 14,295 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
| MEDICINES CO | COM | 584688105 | 101,626 | 3,636,000 | SH | SOLE | 3,636,000 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | COM | 59045L106 | 19,725 | 3,750,000 | SH | SOLE | 3,750,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 73 | 1,000 | SH | SOLE | 1,000 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 54,965 | 1,417,000 | SH | SOLE | 1,417,000 | 0 | 0 | ||